TFPI and Venous thrombosis: Tissue factor pathway inhibitor (TFPI) is a plasma multivalent Kunitz-type serine protease inhibitor that interacts with FV, and this interaction may alter the formation of venous thrombosis (12) and may be related to cancer progression (13).